Navigation Links
Breakthrough HIV Technology Could Revolutionize Patient Care in Zimbabwe
Date:2/9/2013

Waltham, Massachusetts (PRWEB) February 09, 2013

Alere Inc. is pleased to announce that, with the aid of a revolutionary point-of-care device, World Health Clinicians, a US-based nongovernmental organization, were able to provide absolute CD4 counts for patients living with HIV in rural Zimbabwe in under 20 minutes. This outcome is the result of a proof-of-concept evaluation World Health Clinicians performed in conjunction with the Zimbabwean Ministry of Health. Zimbabwe has a population of approximately 11.6 million people, 1.2 million of whom are infected with HIV.

In HIV-infected individuals, total CD4 count is the most robust surrogate marker for immune competence, identifying when patients need to start life-saving, antiretroviral therapy. As part of its evaluation, the World Health Clinicians team ran rapid HIV screening tests as well as total CD4 cell counts, providing a complete set of results in less than one hour, a service that is currently unavailable in even the most developed parts of the world. More information about the evaluation and its results can be found by accessing the link below.

VIDEO    http://alerehiv.com/video/alere-pima-cd4-in-zimbabwe/

Designed and engineered in Germany, the Alere Pima™ CD4 test provides an accurate, absolute CD4 count using a small amount of blood drawn from a fingerstick. The analyzer weighs 2.5kg (5.5lbs) and runs on either battery or A/C power, allowing for easy transport and use in even the most remote and challenging environments.

In particular, the Alere Pima™ CD4 test enabled the team from World Health Clinicians to conduct house-to-house CD4 testing outside the clinic, reaching patients who would otherwise go without results. Moreover, when the clinic lost power for 3 ½ hours, a common occurrence in the region, the team was able to switch to battery-operated power and continue CD4 testing.

“I think this is one of the most practical systems I’ve ever seen–for the fact that it’s so lightweight, it lasts so long with the back-up battery, and it takes twenty minutes and a single fingerstick to run,” said Dr Gary Blick, CEO of World Health Clinicians. “I would love to have access to this in the United States.”

Alere, a leading provider of near-patient diagnostics, is committed to developing solutions that support the screening and monitoring of people living with HIV. The company manufactures a range of point-of-care diagnostics for HIV screening, monitoring and the detection of such co-morbidities as tuberculosis, including the Alere Determine™ HIV-1/2 and the Alere Determine™ TB LAM Ag tests.

For more information about Alere’s diagnostic tools for chronic HIV management, go to http://www.AlereHIV.com.

About Alere
By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit http://www.alere.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10411079.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
2. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
3. An important breakthrough in immunology by IRCM researchers
4. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
5. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
6. Breakthrough Brings Transparency to Male/Female Relationships
7. Breakthrough treatment reduces post-surgical scarring for glaucoma patients
8. Research breakthrough could halt melanoma metastasis
9. Breakthrough nanoparticle halts multiple sclerosis
10. Nanomedicine breakthrough could improve chemotherapy for childhood cancer
11. Western University researchers make breakthrough in arthritis research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Bill Howe Plumbing, Heating ... the American Heart Association; “Howe” Healthy is Your Heart Drawing Contest The ... active. Each year, Bill Howe Plumbing, Heating & Air receives over 600 entries. The ...
(Date:1/19/2017)... Marriottsville, MD (PRWEB) , ... January 19, 2017 , ... ... launched six new clients into the US market. , Over the past 20 years ... the past 4 weeks SFI has launched six new clients into the US market. ...
(Date:1/19/2017)... Georgia (PRWEB) , ... January 19, 2017 , ... ... Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons ... advancements in breast surgery. Covering topics from cosmetic breast augmentation to ...
(Date:1/18/2017)... ... 2017 , ... A recent video posting of a new fidget product gathered ... fidgeting to relieve stress and anxiety. No one was more surprised than Think ... just completed a successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... manage it from the number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive ... go untreated. , Certain Dri created this infographic to explain the seven types ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017   Science ... is excited to announce that the first five ... Biology  (RP:CB) have been published in eLife today. ... project represents the first practical evaluation of reproducibility ... in reproducible studies. Unlike other assessments of reproducibility, ...
(Date:1/19/2017)... -- New Review of Safinamide - ... and Motor Complications in Mid- to Late-stage Parkinson,s ... ... C Warren Olanow , ... 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published recently ...
Breaking Medicine Technology: